These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 27566285)
21. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension. Wang X; Li G; Abdel-Rahman AA Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolines. Saczewski J; Hudson A; Scheinin M; Rybczynska A; Ma D; Saczewski F; Laird S; Laurila JM; Boblewski K; Lehmann A; Gu J; Watts H Bioorg Med Chem; 2012 Jan; 20(1):108-16. PubMed ID: 22172308 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors. Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological activity of some 2-imidazolinylhydrazone derivatives. Kornicka A; Hudson AL; Bednarski PJ Acta Pol Pharm; 2009; 66(5):523-34. PubMed ID: 19894648 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity. Kulig K; Sapa J; Maciag D; Filipek B; Malawska B Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129 [TBL] [Abstract][Full Text] [Related]
27. Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs. Bruban V; Feldman J; Greney H; Dontenwill M; Schann S; Jarry C; Payard M; Boutin J; Scalbert E; Pfeiffer B; Renard P; Vanhoutte P; Bousquet P Br J Pharmacol; 2001 May; 133(2):261-6. PubMed ID: 11350862 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity. Malawska B; Kulig K; Filipek B; Sapa J; Maciag D; Zygmunt M; Antkiewicz-Michaluk L Eur J Med Chem; 2002 Mar; 37(3):183-95. PubMed ID: 11900863 [TBL] [Abstract][Full Text] [Related]
29. (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor. Bell MG; Gernert DL; Grese TA; Belvo MD; Borromeo PS; Kelley SA; Kennedy JH; Kolis SP; Lander PA; Richey R; Sharp VS; Stephenson GA; Williams JD; Yu H; Zimmerman KM; Steinberg MI; Jadhav PK J Med Chem; 2007 Dec; 50(26):6443-5. PubMed ID: 18038968 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3- piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones. Chłoń-Rzepa G; Pawłowski M; Zygmunt M; Filipek B; Maciag D Pol J Pharmacol; 2004; 56(6):755-66. PubMed ID: 15662088 [TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities. Handzlik J; Bajda M; Zygmunt M; Maciąg D; Dybała M; Bednarski M; Filipek B; Malawska B; Kieć-Kononowicz K Bioorg Med Chem; 2012 Apr; 20(7):2290-303. PubMed ID: 22381672 [TBL] [Abstract][Full Text] [Related]
38. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity. Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567 [TBL] [Abstract][Full Text] [Related]
39. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine. Chan CK; Burke SL; Head GA J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186 [TBL] [Abstract][Full Text] [Related]
40. Radiosynthesis and evaluation of new α1-adrenoceptor antagonists as PET radioligands for brain imaging. Airaksinen AJ; Finnema SJ; Balle T; Varnäs K; Bang-Andersen B; Gulyás B; Farde L; Halldin C Nucl Med Biol; 2013 Aug; 40(6):747-54. PubMed ID: 23810488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]